![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
KH Dykstra, A Arya, DM Arriola, PM Bungay, PF Morrison and RL Dedrick
Biomedical Engineering and Instrumentation Program, National Institutes of Health, Bethesda, Maryland.
The concentration profiles of [14C]3'-azido-3'-deoxythymidine (AZT) emanating from an acutely implanted microdialysis probe were measured in rat caudate putamen by quantitative autoradiography for infusions of 14 min and 1 and 2 h. A mathematical model which simulated diffusive solute transport, unaffected by the processes of microvascular exchange or tissue metabolism, did not fit the observed concentration profiles. Chromatographic analysis of brain homogenates for metabolites of AZT showed that the rate of metabolic transformation was not large enough to affect transport of the drug through the brain tissue. A model simulating the effect of microvascular exchange on the diffusion profiles fit the observed concentration profiles and the transient change in the dialysate extraction fraction. This analysis yielded an estimated tissue elimination rate constant for microvascular exchange of Kel = 0.013 ml/(g.min) and an intra- to extracellular partition coefficient of K pi = 1.04. Inclusion of probenecid in the dialysate, together with an i.p. injection, led to a substantial increase in the diffusion distance of the labeled AZT from the microdialysis probe, suggesting at least a 4-fold decrease in the microvascular exchange rate constant. These results imply that AZT is actively transported out of the brain parenchyma to the microvasculature and that this active transport mechanism is responsible for the limited central nervous system penetration of systemically administered AZT, in spite of its high lipid solubility.
This article has been cited by other articles:
|
|
 |
|
  M. Muller, A. dela Pena, and H. Derendorf Issues in Pharmacokinetics and Pharmacodynamics of Anti-Infective Agents: Distribution in Tissue Antimicrob. Agents Chemother., May 1, 2004; 48(5): 1441 - 1453. [Full Text] [PDF]
|
|
|
|
 |
|
 E. Fox, P. M. Bungay, J. Bacher, C. L. McCully, R. L. Dedrick, and F. M. Balis Zidovudine Concentration in Brain Extracellular Fluid Measured by Microdialysis: Steady-State and Transient Results in Rhesus Monkey J. Pharmacol. Exp. Ther., June 1, 2002; 301(3): 1003 - 1011. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Sun, P. M. Bungay, and W. F. Elmquist Effect of Capillary Efflux Transport Inhibition on the Determination of Probe Recovery During in Vivo Microdialysis in the Brain J. Pharmacol. Exp. Ther., June 1, 2001; 297(3): 991 - 1000. [Abstract] [Full Text]
|
|
|
|
|
|
M. B. Hesselink, H. Smolders, B. Eilbacher, A. G. De Boer, D. D. Breimer, and W. Danysz The Role of Probenecid-Sensitive Organic Acid Transport in the Pharmacokinetics of N-Methyl-D-Aspartate Receptor Antagonists Acting at the GlycineB-Site: Microdialysis and Maximum Electroshock Seizures Studies J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 543 - 550. [Abstract] [Full Text]
|
|
|
|
|
|
J.-i. Nishino, H. Suzuki, D. Sugiyama, T. Kitazawa, K. Ito, M. Hanano, and Y. Sugiyama Transepithelial Transport of Organic Anions across the Choroid Plexus: Possible Involvement of Organic Anion Transporter and Multidrug Resistance-Associated Protein J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 289 - 294. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Török, J. Huwyler, J. Drewe, H. Gutmann, and G. Fricker Transport of the beta -Lactam Antibiotic Benzylpenicillin and the Dipeptide Glycylsarcosine by Brain Capillary Endothelial Cells In Vitro Drug Metab. Dispos., November 1, 1998; 26(11): 1144 - 1148. [Abstract] [Full Text]
|
|
|
|
|
|
T. Kitazawa, T. Terasaki, H. Suzuki, A. Kakee, and Y. Sugiyama Efflux of Taurocholic Acid Across the Blood-Brain Barrier: Interaction with Cyclic Peptides J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 890 - 895. [Abstract] [Full Text]
|
|
|
|
|
|
T. Ooie, T. Terasaki, H. Suzuki, and Y. Sugiyama Kinetic Evidence for Active Efflux Transport across the Blood-Brain Barrier of Quinolone Antibiotics J. Pharmacol. Exp. Ther., October 1, 1997; 283(1): 293 - 304. [Abstract] [Full Text]
|
|
|
|
|
|
K. Takasawa, T. Terasaki, H. Suzuki, T. Ooie, and Y. Sugiyama Distributed Model Analysis of 3'-Azido-3'-Deoxythymidine and 2',3'-Dideoxyinosine Distribution in Brain Tissue and Cerebrospinal Fluid J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1509 - 1517. [Abstract] [Full Text]
|
|
|
|
|
|
T. Ooie, T. Terasaki, H. Suzuki, and Y. Sugiyama Quantitative Brain Microdialysis Study on the Mechanism of Quinolones Distribution in the Central Nervous System Drug Metab. Dispos., July 1, 1997; 25(7): 784 - 789. [Abstract] [Full Text]
|
|
|
|
|
|
K. Takasawa, T. Terasaki, H. Suzuki, and Y. Sugiyama In Vivo Evidence for Carrier-Mediated Efflux Transport of 3'-Azido-3'-Deoxythymidine and 2',3'-Dideoxyinosine Across the Blood-Brain Barrier via a Probenecid-Sensitive Transport System J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 369 - 375. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Deguchi, K. Nozawa, S. Yamada, Y. Yokoyama, and R. Kimura Quantitative Evaluation of Brain Distribution and Blood-Brain Barrier Efflux Transport of Probenecid in Rats by Microdialysis: Possible Involvement of the Monocarboxylic Acid Transport System J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 551 - 560. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
